Membrane-active peptide PV3 efficiently eradicates multidrug-resistant Pseudomonas aeruginosa in a mouse model of burn infection

APMIS. 2018 Feb;126(2):114-122. doi: 10.1111/apm.12791. Epub 2018 Jan 12.

Abstract

The aim of this study was to evaluate the topical bactericidal activity of peptide PV3 against a MDR isolate of Pseudomonas aeruginosa in a mouse model of burn infection. The structural analysis of PV3 by circular dichroism spectroscopy indicated a low peptide helical content in water, whereas a high helical content was observed in the presence of the more hydrophobic 50% (v/v) trifluoroethanol/water buffer. A confocal microscopy analysis indicated that the main action of PV3 occurred at the membrane of bacteria. Peptide PV3 exhibited superior in vitro anti-Pseudomonas activity and killing kinetics as compared with doripenem. A single dose of the topically applied peptide PV3 (4 × MBC, 120 min) was found to be sufficient to eradicate MDRP. aeruginosa in a bacterially infected mouse burn wound model, whereas doripenem (4 × MBC) failed to eradicate the initial inoculum. This indicates a potent and fast PV3-associated bactericidal activity, contrary to doripenem. An in-depth analysis of mouse skin by histopathology revealed that peptide PV3 (4 × MBC) did not induce any topical skin toxicity. Overall, the data strongly suggest that peptide PV3 might be a potent candidate antimicrobial agent active on antibiotic-resistant isolates of pathogenic bacteria.

Keywords: Pseudomonas aeruginosa; antimicrobial peptides; burn infection; mouse model.

MeSH terms

  • Animals
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / therapeutic use*
  • Burns / complications*
  • Circular Dichroism
  • Drug Resistance, Multiple, Bacterial
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Pseudomonas aeruginosa / drug effects*
  • Skin / pathology
  • Wound Infection / drug therapy*
  • Wound Infection / microbiology

Substances

  • Antimicrobial Cationic Peptides